The purpose of this study was to demonstrate that the PP can be improved in chronic stroke survivors using a newly developed, intensive training. The effect of the new training on the PP, walking velocity and mobility at home will be determined.…
ID
Source
Brief title
Condition
- Central nervous system vascular disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary outcome is the propulsion symmetry measured during walking at a
comfortable, self-selected walking velocity.
Secondary outcome
Secondary parameters are 1) Walking velocity, 2) mobility at home, 3)
determinants for the improvement in PP and 4) the score on the maximal step
length test.
Background summary
Although most stroke survivors regain a (near) normal gait pattern, the walking
velocity is slower. A possible explanation for the low walking velocity in
stroke survivors is the decreased anterior ground reaction force that is
achieved by the paretic leg (*paretic propulsion (PP)*). Interventions aiming
to improve the PP in stroke survivors show a large variability in the response
to the training. Outcomes suggest that part of the stroke survivors have a
relevant, unused residual capacity in PP, which can be addressed by targeted
task-oriented training. However, it is yet unknown who responds well to the
training.
Study objective
The purpose of this study was to demonstrate that the PP can be improved in
chronic stroke survivors using a newly developed, intensive training. The
effect of the new training on the PP, walking velocity and mobility at home
will be determined. Furthermore, determinants for the improvements in PP will
be investigated. We strive to identify stroke survivors who will achieve a
minimal gain in PP following the training using the maximal step length test,
without the use of a gait laboratory.
Study design
The proposed study is an intervention study with multiple baseline design.
Intervention
Subjects receive two times per week gait training in gait robot LOPES II for 60
minutes per session during five weeks. The training will be complemented with
daily home-based exercises, to practice the developed skills and gait
strategies. Participants receive an individually tailored exercise program.
Study burden and risks
The gait training in the LOPES II is safe, although some subjects may
experience small irritations of the skin due to the attachment to the LOPES II.
During the measurements there is a chance that subjects might lose their
balance. The chances that performing these tasks will lead to fall are not
higher than during daily life. Subjects are allowed to take rest during the
training and between the different measurements. The training and the
measurements will be accomplished by an experienced physiotherapist who will
take care of the patient.
Hengstdal 3
Ubbergen 6574 NA
NL
Hengstdal 3
Ubbergen 6574 NA
NL
Listed location countries
Age
Inclusion criteria
- Adults (> 18 years) with an unilateral ischemic of haemorrhagic supratentorial stroke
- Time post stroke > 6 months
- Ability to walk at least 10 meters without the use of a AFO, walking aid or physical assistance from a person (FAC score 3-5, range 0-5)
- Ability to walk at least 5 minutes (assistive devices allowed)
- At least 8% propulsion asymmetry during gait at comfortable speed
- At least 10° passive hip extension and ability to stand with extended knees and plantigrade feet
- Ability to stand on the toes for 3 seconds, with symmetrical weight bearing between legs (MRC-score calf muscles * 3, range 0-5)
- Stable cardiovascular and general medical condition
- Sufficient communication ability (Utrechts Communicatie Onderzoek > 2)
- Signed informed consent
Exclusion criteria
- Insufficient mastery of the Dutch language
- Other disorders interfering with gait, like neurological and orthopaedic disorders, or recent orthopaedic interventions (within 6 months)
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL62617.091.17 |